Regulation of cardiac fibroblasts by lymphocytes after a myocardial infarction: playing in the major league

Am J Physiol Heart Circ Physiol. 2023 Sep 1;325(3):H553-H561. doi: 10.1152/ajpheart.00250.2023. Epub 2023 Jul 14.

Abstract

Cardiac fibrosis is a pathological condition characterized by excessive accumulation of extracellular matrix components within the myocardium, which can lead to impaired cardiac function and heart failure. Studies have shown that lymphocytes including B and T cells play important roles in the development and progression of cardiac fibrosis after a myocardial infarction. In this review, we focus on the regulation of cardiac fibrosis by lymphocyte subsets, with a particular emphasis on CD4+ and CD8+ T cells and their effects on fibroblasts and cardiac remodeling. We also highlight areas for further exploration of the interactions between T cells and fibroblasts necessary for understanding and treating cardiac fibrosis and heart failure.

Keywords: B cells; T cells; fibroblasts; fibrosis; myocardial infarction.

Publication types

  • Review
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, N.I.H., Extramural

MeSH terms

  • CD8-Positive T-Lymphocytes
  • Cardiomyopathies* / pathology
  • Fibroblasts / pathology
  • Fibrosis
  • Heart Failure* / pathology
  • Humans
  • Myocardial Infarction* / pathology
  • Myocardium / pathology
  • Ventricular Remodeling